Incidence and risk factors of prolonged QTc interval in type 1 diabetes - The EURODIAB Prospective Complications Study

被引:32
|
作者
Giunti, Sara
Bruno, Graziella
Lillaz, Emma
Gruden, Gabriella
Lolli, Valentina
Chaturvedi, Nish
Fuller, John H.
Veglio, Massimo
Cavallo-Perin, Paolo
机构
[1] Univ Turin, Dept Internal Med, I-10126 Turin, Italy
[2] Imperial Coll Sch Med, Int Ctr Circulatory Hlth & Natl Heart & Lung Inst, London, England
[3] Osped Evangelico Valdese, Turin, Italy
基金
英国惠康基金;
关键词
D O I
10.2337/dc07-0063
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - Corrected QT (QTc) prolongation is predictive of cardiovascular mortality in both the general and diabetic populations. As part of the EURODIAB Prospective Complication Study, we have assessed the 7-year incidence and risk factors of prolonged QTc in people with type 1 diabetes. RESEARCH DESIGN AND METHODS - A total of 1,415 type 1 diabetic subjects, who had normal QTc at baseline, were reanalyzed after the 7-year follow-up period. QTc >0.44 s was considered abnormally prolonged. RESULTS - Cumulative incidence of prolonged QTc was 18.7%, which is twofold higher in women than in men (24.5 vs. 13.9%, P < 0.0001). At the baseline examination, incident cases were older and less physically active than nonincident cases, had higher mean values of systolic blood pressure and HDL cholesterol, and had higher frequencies of hypertension, coronary heart disease, and distal symmetrical polyneuropathy. In multivariate logistic regression analyses, female sex and higher values of A I C and systolic blood pressure were associated with the risk of prolonged QTc. whereas physical activity and BMI within the range of 21.5-23.2 kg/m(2) were protective factors. In women, association with modifiable factors, particularly BMI, was stronger than in men. CONCLUSIONS - in type I diabetic subjects from the EURODIAB cohort, female sex, A 1 C, and systolic blood pressure are predictive of prolonged QTc, whereas physical activity and BMI within the range of 21.5-23.2 kg/m(2) play a protective role. These findings are clinically relevant, as they may help to identify subjects at higher risk for prolonged QTc, as well as provide potential targets for risk-lowering strategies.
引用
收藏
页码:2057 / 2063
页数:7
相关论文
共 50 条
  • [41] Advanced glycation end products are associated with pulse pressure in type 1 diabetes - The EURODIAB Prospective Complications Study
    Schram, MT
    Schalkwijk, CG
    Bootsma, AH
    Fuller, JH
    Chaturvedi, N
    Stehouwer, CDA
    HYPERTENSION, 2005, 46 (01) : 232 - 237
  • [42] Is pregnancy a risk factor for microvascular complications?: The EURODIAB Prospective Complications Study
    Vérier-Mine, O
    Chaturvedi, N
    Webb, D
    Fuller, JH
    DIABETIC MEDICINE, 2005, 22 (11) : 1503 - 1509
  • [43] Serum MicroRNA-191-5p Levels in Vascular Complications of Type 1 Diabetes: The EURODIAB Prospective Complications Study
    Bellini, Stefania
    Guarrera, Simonetta
    Matullo, Giuseppe
    Schalkwijk, Casper
    Stehouwer, Coen D.
    Chaturvedi, Nish
    Soedamah-Muthu, Sabita S.
    Barutta, Federica
    Gruden, Gabriella
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 109 (01): : e163 - e174
  • [44] Serum MicroRNA-191-5p Levels in Vascular Complications of Type 1 Diabetes: The EURODIAB Prospective Complications Study
    Bellini, Stefania
    Guarrera, Simonetta
    Matullo, Giuseppe
    Schalkwijk, Casper
    Stehouwer, Coen D.
    Chaturvedi, Nish
    Soedamah-Muthu, Sabita S.
    Barutta, Federica
    Gruden, Gabriella
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (01): : e163 - e174
  • [45] ACUTE COMPLICATIONS IN INSULIN-DEPENDENT (TYPE-1) DIABETES - THE EURODIAB COMPLICATIONS STUDY
    KERENYI, Z
    NUNESCORREA, J
    SANTEUSANIO, F
    DIABETOLOGIA, 1992, 35 : A183 - A183
  • [46] Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes—the EURODIAB Prospective Complications Study
    M. T. Schram
    N. Chaturvedi
    C. G. Schalkwijk
    J. H. Fuller
    C. D. A. Stehouwer
    Diabetologia, 2005, 48 : 370 - 378
  • [47] The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM Complication Study Group
    Veglio, M
    Borra, M
    Stevens, LK
    Fuller, JH
    Perin, PC
    DIABETOLOGIA, 1999, 42 (01) : 68 - 75
  • [48] Association of serum MicroRNA-145-5p levels with microvascular complications of type 1 Diabetes: The EURODIAB prospective complications study
    Barutta, Federica
    Bellini, Stefania
    Guarrera, Simonetta
    Matullo, Giuseppe
    Schalkwijk, Casper
    Stehouwer, Coen D.
    Chaturvedi, Nish
    Soedamah-Muthu, Sabita S.
    Durazzo, Marilena
    Gruden, Gabriella
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 190
  • [49] The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM Complication Study Group
    M. Veglio
    M. Borra
    L. K. Stevens
    J. H. Fuller
    P. C. Perin
    Diabetologia, 1999, 42 : 68 - 75
  • [50] Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes - the EURODIAB Prospective Complications Study
    Schram, MT
    Chaturvedi, N
    Schalkwijk, CG
    Fuller, JH
    Stehouwer, CDA
    DIABETOLOGIA, 2005, 48 (02) : 370 - 378